))
Aspira Women’s Health CEO Nicole Sandford on OvaWatch Progress and Recent Financing
Manage episode 429334557 series 3486351
内容由Water Tower Research提供。所有播客内容（包括剧集、图形和播客描述）均由 Water Tower Research 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Aspira CEO and Director Nicole Sandford joins the Water Tower Hour Podcast to discuss recent updates on OvaSuite, including preliminary 2Q24 OvaWatch volume growth and the launch of mass monitoring. She walks us through what is driving OvaWatch growth and the messaging to physicians and patients around the value of proper malignancy risk assessment prior to surgical intervention. In addition, she reviews the recent private placement financing and potential opportunities for the company’s biobank of patient samples, including academic collaborations.
99集单集
分享
